Qianqian Xue
Shanghai, 200040, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma.
Journal: Cell reports. Medicine
Published: January 14, 2026
Diagnostic accuracy of NGAL and HBP for the diagnosis of acute bacterial meningitis.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: October 16, 2025
MET Exon 14 Skipping Mutations in Lung Cancer: Clinical-Pathological Characteristics and Immune Microenvironment.
Journal: Current oncology (Toronto, Ont.)
Published: May 26, 2025
An alternative method for inferring Pandy's test using cerebrospinal fluid total protein.
Journal: Practical laboratory medicine
Published: February 29, 2024
Development of an Interpretable Deep Learning Model for Pathological Tumor Response Assessment After Neoadjuvant Therapy.
Journal: Biological procedures online
Published: January 05, 2024
GPRC5A is a potential prognostic biomarker and correlates with immune cell infiltration in non-small cell lung cancer.
Journal: Translational lung cancer research
Published: November 18, 2023
POU2F3: A Sensitive and Specific Diagnostic Marker for Neuroendocrine-low/negative Small Cell Lung Cancer.
Journal: The American journal of surgical pathology
Published: June 26, 2023
Evolutionary proteogenomic landscape from pre-invasive to invasive lung adenocarcinoma.
Journal: Cell reports. Medicine
Published: January 24, 2023
Prognostic value of tumor immune microenvironment factors in patients with stage I lung adenocarcinoma.
Journal: American journal of cancer research
Published: December 28, 2022
Frequent EGFR exon 20 insertion in the so-called peripheral-type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under-recognised entity?
Journal: Histopathology
Published: October 03, 2022
Construction of a prognostic immune-related lncRNA model and identification of the immune microenvironment in middle- or advanced-stage lung squamous carcinoma patients.
Journal: Heliyon
Published: January 11, 2022
Last Updated: 09/26/2026